Quadazocine

Quadazocine is a synthetic compound that belongs to the benzomorphan class of opioids. It was developed in the 1960s and has been studied for its potential use in the treatment of pain and drug addiction. Quadazocine is a kappa opioid receptor agonist, which means it activates these receptors in the brain to produce its effects.

History[edit | edit source]

Quadazocine was first synthesized in the 1960s by the pharmaceutical company Sterling Drug. It was part of a series of compounds developed to explore the therapeutic potential of kappa opioid receptor agonists. Early studies showed that quadazocine had potent analgesic effects, but its development was ultimately discontinued due to undesirable side effects.

Pharmacology[edit | edit source]

Quadazocine is a kappa opioid receptor agonist. This means it binds to and activates these receptors in the brain. Kappa opioid receptors are one of several types of opioid receptors in the brain, and they are involved in pain perception, mood, and the body's response to stress. Activation of these receptors by quadazocine produces analgesic effects, making it potentially useful for the treatment of pain.

In addition to its effects on kappa opioid receptors, quadazocine also has some activity at other opioid receptors. It is a partial agonist at mu opioid receptors, which are the primary target of most opioid painkillers. It also has some antagonist activity at delta opioid receptors.

Clinical Use[edit | edit source]

Despite its potent analgesic effects, quadazocine has not been widely used in clinical practice. This is primarily due to its side effects, which can include sedation, dysphoria (a state of unease or dissatisfaction), and hallucinations. These effects are thought to be related to its activity at kappa opioid receptors.

Research[edit | edit source]

Research into the therapeutic potential of quadazocine and other kappa opioid receptor agonists continues. These compounds may have potential in the treatment of conditions such as chronic pain, opioid addiction, and mood disorders. However, the development of drugs in this class has been challenging due to the complex pharmacology of the kappa opioid receptor and the difficulty of separating the desired therapeutic effects from unwanted side effects.

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Translate this page: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.